Oblique Therapeutics announces that NaV 1.8 project is advancing to next stage

STOCKHOLM, Oct. 22, 2024 /PRNewswire/ -- Oblique Therapeutics AB ("Oblique") announces that the company's research project on the NaV1.8 ion channel has reached an important milestone. After successfully completing the first stage of the project, where the Company's AbiProt technology is...